Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Dimension Management, L.P. reported a 8.10% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 22, 2026
Dimension Management, L.P. reported a 8.10% stake in Monte Rosa Therapeutics, Inc., 6,513,765 shares, as a passive investor on Mar 31, 2026. Filed Apr 22, 2026 (Schedule 13G/A).
- Stake
- 8.10%
- Shares
- 6,513,765
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adam Goulburn | 8.10% | 6,513,765 |
| Zavain Dar | 8.10% | 6,513,765 |
| Nan Li | 8.10% | 6,513,765 |
| Dimension Management, L.P. | 8.10% | 6,513,765 |
| Dimension Capital I GP, LLC | 7.10% | 5,663,265 |
| Dimension Management GP, LLC | 8.10% | 6,513,765 |
| Dimension Capital I, L.P. | 7.10% | 5,663,265 |
| Dimension Capital II, L.P. | 1.10% | 850,500 |
| Dimension Capital II GP, LLC | 1.10% | 850,500 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Dimension Management, L.P.
- Monte Rosa Therapeutics, Inc. shareholders
- Schedule 13G/A · Dimension Management, L.P. · Jan 21, 2026
- Schedule 13G · Dimension Management, L.P. · Oct 3, 2025
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026